rxstat › Shortages › Corynebacterium Diphtheriae Crm-197 Protein Meningococcal Group C Oligosaccharide W-135 A Y

Corynebacterium Diphtheriae Crm-197 Protein Meningococcal Group C Oligosaccharide W-135 A Y (Menveo) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Corynebacterium Diphtheriae Crm-197 Protein Meningococcal Group C Oligosaccharide W-135 A Y has no current shortage reported in Canada. It has been in shortage before; the history is below.

A vaccine that helps protect against meningococcal disease caused by groups A, C, W and Y.

Products affected

0 / 1

Reports on file

Shortage history

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Resolved

MENVEO

47MCG 5MCG 5MCG 10MCG 5MCG · POWDER FOR SOLUTION SOLUTION · GLAXOSMITHKLINE INC

DIN 02347393 · ended Oct 24, 2025 · Disruption of the manufacture of the drug.

Resolved

MENVEO

5MCG 47MCG 10MCG 5MCG 5MCG · SOLUTION POWDER FOR SOLUTION · GLAXOSMITHKLINE INC

DIN 02347393 · ended Aug 28, 2019 · Disruption of the manufacture of the drug.

Resolved

MENVEO

5MCG 47MCG 10MCG 5MCG 5MCG · SOLUTION POWDER FOR SOLUTION · GLAXOSMITHKLINE INC

DIN 02347393 · ended Apr 8, 2019

Resolved

MENVEO

5MCG 47MCG 10MCG 5MCG 5MCG · SOLUTION POWDER FOR SOLUTION · GLAXOSMITHKLINE INC

DIN 02347393 · ended Jan 17, 2018 · Delay in shipping of the drug.

What's happening

There are no active shortage reports for Corynebacterium Diphtheriae Crm-197 Protein Meningococcal Group C Oligosaccharide W-135 A Y. Health Canada has 4 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Corynebacterium Diphtheriae Crm-197 Protein Meningococcal Group C Oligosaccharide W-135 A Y is classified under “BACTERIAL VACCINES” (ATC J07AH).

Recent changes

No changes recorded yet.

Common questions

What is Corynebacterium Diphtheriae Crm-197 Protein Meningococcal Group C Oligosaccharide W-135 A Y used for?

A vaccine that helps protect against meningococcal disease caused by groups A, C, W and Y.

When will Corynebacterium Diphtheriae Crm-197 Protein Meningococcal Group C Oligosaccharide W-135 A Y be back in stock in Canada?

Corynebacterium Diphtheriae Crm-197 Protein Meningococcal Group C Oligosaccharide W-135 A Y has no active shortage; supply is normal per Health Canada reports.

Why is Corynebacterium Diphtheriae Crm-197 Protein Meningococcal Group C Oligosaccharide W-135 A Y in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (bacterial vaccines)

Boostrix (Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussi…) Partial shortage 1 of 1 reported products affected · est. return Aug 31, 2026 Prevnar (Corynebacterium Diphtheriae Crm-197 Protein Pneumococcal Pol…) Discontinued 0 of 1 reported products affected Capvaxive (Corynebacterium Diphtheriae Crm-197 Protein Pneumococcal Pol…) No current shortage Hiberix (Haemophilus Influenzae Type B-prp / Tetanus Toxoid Conjugate) Discontinued 0 of 1 reported products affected Menjugate (Meningococcal Group C Oligosaccharide Corynebacterium Diphth…) Discontinued 0 of 2 reported products affected Menomune-A/C/Y/W-135 (Meningococcal Polysaccharide Antigen Group A C W-135 Y) Discontinued 0 of 2 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.